SEP 8, 2026 · JOURNAL ARTICLE
Transmembrane lectins in cancer immunity: emerging drivers of myeloid-mediated immunosuppression
Frontiers in Immunology
A narrative review synthesizing mechanistic concepts and therapeutic potential of lectin–glycan interactions in cancer immunity, raising questions rather than reporting empirical results or clinical outcomes.